Related references
Note: Only part of the references are listed.The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme
Francesco Bellia et al.
JOURNAL OF MASS SPECTROMETRY (2014)
Insulin-degrading Enzyme (IDE) A NOVEL HEAT SHOCK-LIKE PROTEIN
Grazia Raffaella Tundo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Formation of insulin fragments by insulin-degrading enzyme: the role of zinc(II) and cystine bridges
Francesco Bellia et al.
JOURNAL OF MASS SPECTROMETRY (2013)
Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity
Samer O. Abdul-Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
Lauren A. McCord et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Evaluation of Taylor dispersion injections: Determining kinetic/affinity interaction constants and diffusion coefficients in label-free biosensing
John G. Quinn
ANALYTICAL BIOCHEMISTRY (2012)
Metal ions affect insulin-degrading enzyme activity
Giuseppe Grasso et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Crypteins derived from the mouse neuropeptide FF (NPFF)A precursor display NPFF-like effects in nociceptive tests in mice
Jolanta H. Kotlinska et al.
PEPTIDES (2012)
Analyzing the Cryptome: Uncovering Secret Sequences
Parimal Samir et al.
AAPS JOURNAL (2011)
Copper(I) and Copper(II) Inhibit Aβ Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer's Disease
Giuseppe Grasso et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Physiological effects of manipulating the level of insulin-degrading enzyme in insulin-producing cells of Drosophila
Joogyung Hyun et al.
FLY (2011)
Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme
Giuseppe Grasso et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2009)
Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme
Marika Manolopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study
Giuseppe Grasso et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Somatostatin: A Novel Substrate and a Modulator of Insulin-Degrading Enzyme Activity
Chiara Ciaccio et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Increased expression of Aβ degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology
Saila Vepsalainen et al.
NEUROSCIENCE LETTERS (2008)
A novel cryptic peptide derived from the rat neuropeptide FF precursor reverses antinociception and conditioned place preference induced by morphine
Tomasz Dylag et al.
PEPTIDES (2008)
Cryptic peptide derived from the rat neuropeptide FF precursor affects G-proteins linked to opioid receptors in the rat brain
Piotr Suder et al.
PEPTIDES (2008)
A new methodology for monitoring the activity of cdMMP-12 anchored and freeze-dried on Au(111)
Giuseppe Grasso et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2007)
The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol
Jolanta Kotlinska et al.
NEUROPEPTIDES (2007)
Cryptides: Functional cryptic peptides hidden in protein structures
Nobuhiko Ueki et al.
BIOPOLYMERS (2007)
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Yuequan Shen et al.
NATURE (2006)
The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities
DJ Autelitano et al.
DRUG DISCOVERY TODAY (2006)
Opioid-modulating peptides: Mechanisms of action
C Mollereau et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Biological activity of a fragment of insulin
WC Duckworth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
